Newly Formed Company Poised for Sustained Growth With a Strengthened Balance Sheet, Resolved Litigation Overhang, Diversified Portfolio of Medicines and a Deep New Product Pipeline MALVERN, Pa., April 23, 2024 /PRNewswire/ — Endo, Inc. (“Endo” or the “Company”), a newly formed entity,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.